Inozyme Pharma Reports Inducement Grants Under Nasdaq

BOSTON, May 03, 2023 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel...

Related Keywords

Boston ,Massachusetts ,United States ,Inozyme Pharma ,Matt Pera ,Stefan Riley ,Twitter ,Inozyme Pharma Inc ,Corporate Communications ,Nasdaq ,Stock Incentive Plan ,Nasdaq Listing Rule ,Nasdaq Inzy ,Nozyme Pharma Inc ,